Page last updated: 2024-10-30

loxoprofen and Gastric Diseases

loxoprofen has been researched along with Gastric Diseases in 2 studies

loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.

Research Excerpts

ExcerptRelevanceReference
"Lafutidine is an H2-receptor antagonist with gastroprotective activity, produced by acting on capsaicin-sensitive afferent neurons."2.75Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a randomized, double-blinded, placebo controlled study. ( Asaka, M; Imai, A; Kamada, G; Kato, M; Nakagawa, M; Nakagawa, S; Nishida, U; Ono, S; Shimizu, Y; Yamamoto, K; Yoshida, T, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanbayashi, Y1
Konishi, H1
Kato, M1
Kamada, G1
Yamamoto, K1
Nishida, U1
Imai, A1
Yoshida, T1
Ono, S1
Nakagawa, M1
Nakagawa, S1
Shimizu, Y1
Asaka, M1

Trials

1 trial available for loxoprofen and Gastric Diseases

ArticleYear
Lafutidine prevents low-dose aspirin and loxoprofen induced gastric injury: a randomized, double-blinded, placebo controlled study.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:10

    Topics: Acetamides; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Ove

2010

Other Studies

1 other study available for loxoprofen and Gastric Diseases

ArticleYear
Predictive Factors for NSAIDs-related Gastrointestinal Toxicity: Can COX-2 Selective Inhibtor Prevent it?.
    Hepato-gastroenterology, 2015, Volume: 62, Issue:140

    Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplast

2015